£0
The oversubscribed venture round was structured under a convertible loan note with participation from existing investors.
"we’re pleased to welcome onboard our new partners at Serafund, who bring unique insights from building and backing world-class technology businesses. We’re also grateful for the support from our existing investors, who remain as convicted as ever to the vision of transforming the patient experience and pharmaceutical value chain through digitally enabling thousands of high street pharmacies."